Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial
Titel:
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial
Auteur:
Peters, S. Felip, E. Dafni, U. Belka, C. Guckenberger, M. Irigoyen, A. Nadal, E. Becker, A. Vees, H. Pless, M. Martinez-Marti, A. Tufman, A. Lambrecht, M. Andratschke, N. Piguet, A.C. Kassapian, M. Roschitzki-Voser, H. Rabaglio-Poretti, M. Stahel, R.A. Vansteenkiste, J. De Ruysscher, D.